Scarica l'app Stockscreener
22.46
1.17%
0.26
Pre-mercato:
21.56
-0.90
-4.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Innoviva Inc Borsa (INVA) Ultime notizie
Innoviva Inc. (INVA) Gains Ground Amid Sector DynamicsThematic ETF Flow - Newser
INNOVIVA INC (NASDAQ:INVA) Scores as a Value Stock with Strong Fundamentals - ChartMill
The Technical Signals Behind (INVA) That Institutions Follow - Stock Traders Daily
INVA Q1 2026 Earnings: EPS Misses Estimates Despite Modest Stock GainOpen Signal Network - Newser
Innoviva (INVA) CFO adds ESPP shares and uses stock to pay taxes - Stock Titan
Innoviva (INVA) CEO logs ESPP share grant and tax withholding on Form 4 - Stock Titan
Innoviva (NASDAQ: INVA) CAO has shares withheld to cover tax obligations - Stock Titan
Innoviva (INVA) Q1 2026 Earnings Miss by Significant: Key TakeawaysHot Momentum Watchlist - Newser
Innoviva Appoints Josephine Linden to Strengthen Board Oversight - TipRanks
Innoviva Board Shakeup Puts Governance And Valuation In Focus - Sahm
Innoviva (INVA) director receives RSU and stock option grants as board compensation - Stock Titan
Innoviva (INVA) director Josephine Linden files Form 3 showing no share ownership - Stock Titan
Innoviva announces board changes and appoints Josephine Linden as director - Investing.com
Innoviva (INVA) refreshes board as two directors resign, adds Josephine Linden - Stock Titan
Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update - Sahm
Armata Pharmaceuticals (ARMP) Q1 2026: EPS -3.16 Misses Est. -0. - GuruFocus
Precision Trading with Innoviva Inc. (INVA) Risk Zones - Stock Traders Daily
Armata Pharmaceuticals (ARMP) now 82.7% owned by Innoviva after new loan - Stock Titan
Armata (NYSE: ARMP) loss, debt surge and Phase 3 bacteremia trial plan - Stock Titan
Armata Pharma Entered Into Secured Credit Agreement With Innoviva for $25 M Maturing in 2029 >ARMP - Moomoo
Press Release: Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update - Moomoo
FDA fast-tracks Armata phage therapy as backer extends $25M loan - Stock Titan
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress - Quantisnow
TradingKey - TradingKey
Why are smart money investors paying attention to Innoviva (INVA)? (Mini Rally) 2026-05-11Professional Trade Ideas - newser.com
Is Innoviva (INVA) Pricing Look Compelling After Recent Share Price Softness? - Yahoo Finance
What Innoviva (INVA)'s Profit Rebound and ESOP Share Filing Means For Shareholders - simplywall.st
Innoviva Inc Emerges as Top Small Cap Value Stock with High Royalty Revenues - HarianBasis.co
Innoviva (INVA) Q1 Profit Swing Challenges Bearish Earnings Decline Narratives - Sahm
Innoviva, Inc. (INVA) Draws Bullish View from Cantor on Recurring Royalty Strength - Insider Monkey
INVA SEC FilingsInnoviva 10-K, 10-Q, 8-K Forms - Stock Titan
BTIG Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $42 - Moomoo
Goldman Sachs Maintains Innoviva(INVA.US) With Sell Rating, Raises Target Price to $18 - Moomoo
MSN Money - MSN
Innoviva: Q1 Earnings Snapshot - theheraldreview.com
Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva (INVA) Tops Q1 Earnings Estimates - Yahoo Finance
Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Innoviva (INVA) grants RSUs and stock options to director Haimovitz - Stock Titan
Earnings Flash (INVA) Innoviva, Inc. Reports Q1 Revenue $98.0M, vs. FactSet Est of $101.6M - marketscreener.com
Innoviva | 10-Q: Q1 2026 Earnings Report - Moomoo
[10-Q] Innoviva, Inc. Quarterly Earnings Report - Stock Titan
Innoviva (NASDAQ: INVA) posts strong Q1 2026 profit on investment gains - Stock Titan
Innoviva (NASDAQ: INVA) director gets RSUs and 10,000 stock options at $22.99 - Stock Titan
Innoviva (INVA) awards RSUs and stock options to accounting chief - Stock Titan
Innoviva (NASDAQ: INVA) director receives RSUs and 10,000 stock options - Stock Titan
[Form 4] Innoviva, Inc. Insider Trading Activity - Stock Titan
Innoviva (NASDAQ: INVA) director granted RSUs and 10,000 stock options - Stock Titan
Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 5, 2025. - marketscreener.com
What Innoviva (INVA) does that builds long term value | Q4 2025: Better Than ExpectedBrand Strength - newser.com
Innoviva Inc (INVA) - MSN
Innoviva, Inc. 8-K SEC Filing – Company Information, Address, and Stock Details for May 2026 - Minichart
Innoviva Shareholders Back Directors, Pay Plan and Incentives - TipRanks
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):